Getryl (glimepiride) is a medication used to control high blood sugar in patients with Type 2 Diabetes. It stimulates the beta cells of the pancreas to produce more insulin and also helps reduce glucose production in the body.

Getryl is commonly used for sugar patients and can be combined with other medications like Metformin or even insulin, especially for patients whose blood sugar is not well-controlled.

The initial dose of Getryl is 1-2 mg per day, which can be increased based on the patient's condition and sugar levels, up to a maximum of 8 mg per day (4 mg in the morning and 4 mg in the evening). Getryl is available in 1mg, 2mg, 3mg, and 4mg strengths.

For patients with kidney disease, the dose should not exceed 1mg. In some cases, if sugar is not controlled, it can be increased to a maximum of 2mg under a doctor's supervision. Patients with kidney or liver problems (elevated ALT levels) should inform their doctor before starting this medication. A fasting blood sugar test is recommended before starting Getryl to help doctors determine the appropriate dose.

An overdose can lead to a drop in blood sugar; in such cases, consuming some glucose can help stabilize it. If a dose is missed, do not double the next dose; simply take the recommended dose at the usual time.